Clinical trial
An Exploratory Study of Esketamine in Patients After Thoracoscopic Surgery
NCT05458453 is registered in ClinicalTrials.gov with The Second Affiliated Hospital of Chongqing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Study of Esketamine in Patients After Thoracoscopic Surgery
- Lead sponsor
- The Second Affiliated Hospital of Chongqing Medical University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 7, 2022
- Completion date
- February 28, 2023
- Enrollment
- 80 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
esketamine, thoracoscopic surgery